BIOLASE Launches State-of-the-Art E-Learning Platform for Dentistry

BIOLASE Campus to Feature Webinars, On-Demand Courses and Clinical Information From International Experts

IRVINE, CA -- (Marketwired) -- 06/03/14 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the company's proprietary WaterLase®, and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography devices, intra-oral scanners, and chairside milling machines and 3-D printers for dentistry, today announced the launch of its state-of-the-art e-learning platform: BIOLASE Campus (www.biolasecampus.com). The site will go live on Monday, June 9, 2014.

With the introduction of six Web-based learning modules initially, BIOLASE underlines its commitment to guiding dentists around the world into the age of digital dentistry.

Federico Pignatelli, Chairman and CEO, said, "BIOLASE acknowledges the need to inform dentists of the multiple benefits new laser and digital technologies offer for patients and dentists alike, and to train dentists in the use of these cutting edge technologies for better dentistry and patient care."

As the world's premier dental laser company, BIOLASE already sponsors a number of educational programs, such as those offered at meetings of the World Clinical Laser & Imaging Institute, and has trained thousands of dental professionals around the world.

"With our expansion of product portfolio into chairside CAD/CAM solutions, 3-D printers, and digital imaging equipment with our laser technology into our Total Technology Solution, we are dedicated to also taking our educational offerings online. By creating an online education platform that will serve BIOLASE's over 25,000 laser clients, as well as dentists interested in incorporating CAD/CAM technologies into their dental offices, the company will greatly expand its services and client base in the upcoming months," Pignatelli concluded.

BIOLASE Campus features free live webinars, on-demand courses, and clinical articles and videos by internationally recognized experts. Participants can study on demand 24/7 and obtain interactive advice from presenters. The online platform is accessible from desktop computers and mobile devices with a high-speed Internet.

About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's proprietary laser products incorporate approximately 300 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 25,500 laser systems. Other laser products under development address ophthalmology and other medical and consumer markets. For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Pinterest at www.pinterest.com/biolase, LinkedIn at www.linkedin.com/company/biolase, Google+ at www.google.com/+BIOLASEIrvine, Instagram at www.instagram.com/biolaseinc, and YouTube.

BIOLASE®, WaterLase®, and Total Technology Solution™ are registered trademarks or trademarks of BIOLASE, Inc.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Statements contained in this press release that refer to BIOLASE's estimated or anticipated future results or other non-historical facts are forward-looking statements, as are any statements in this press release concerning prospects related to BIOLASE's strategic initiatives, product introductions and anticipated financial performance. Forward-looking statements can also be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE's current perspective of existing trends and information and speak only as of the date of this release. Actual results may differ materially from BIOLASE's current expectations depending upon a number of factors affecting BIOLASE's business. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that may be detailed, from time-to-time, in BIOLASE's reports filed with the SEC. BIOLASE does not undertake any responsibility to revise or update any forward-looking statements contained herein.

For further information, please contact:
Michael Porter
Porter, LeVay & Rose, Inc.
212-564-4700

Source: BIOLASE, Inc.